An Evaluation of Generic and Disease-Specific Patient-Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health-Related Quality of Life in a European Population
January 2025
in “
JEADV Clinical Practice
”
Studysummary This study reported that the AAPPO tool effectively distinguishes between patients with alopecia areata based on scalp hair loss severity, whereas the EQ‐5D‐5L may underestimate the specific disease burden, particularly in psychological and social aspects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →